Phase 1 Obsessive-Compulsive Disorder Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Obsessive-Compulsive Disorder
Centre for Addiction and Mental Health10 enrolled1 locationNCT06299319
Recruiting
Phase 1Phase 2
Pilot Study of RR-HNK in OCD
Obsessive-Compulsive Disorder
Carolyn Rodriguez45 enrolled1 locationNCT06575075
Recruiting
Phase 1
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.
Obsessive-Compulsive Disorder
Francisco A Moreno30 enrolled1 locationNCT07347405
Recruiting
Phase 1Phase 2
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
Obsessive-Compulsive Disorder
Yale University100 enrolled1 locationNCT04131829